Background: Blood CXCR5+CD4+ T cells are defined as circulating T follicular helper (TFH) cells, which is required for effective humoral immunity. This study aimed to investigate the role of circulating TFH cells in patients with chronic hepatitis B virus (CHB) infection. Methods: The frequency and phenotype of circulating TFH cells were monitored by flow cytometry in CHB patients and in healthy controls (HC). The expression of BCL-6, IL-21, IL-4, CXCR5, and IL-6R mRNA was analyzed using real-time PCR. Serum HBsAg, HBeAg, HBeAb, HBV DNA loads, ALT and AST were determined. The potential association of the frequency of TFH cells and their surface markers with clinical parameters was assessed.
Introduction
Approximately 350 million people worldwide are carriers of hepatitis B virus (HBV), and half a million to 1 million of these carriers die from liver diseases each year [1] . Therapeutic management of chronic hepatitis B patients can stop or slow the progression of the disease and reduce complications, but it is impossible to eradicate HBV and reverse liver damage [1, 2] . The outcome of infection and the pathogenesis of liver disease are determined by dynamic interactions between the virus and the host immune system [3] . Thus, elucidating the immune mechanisms that underlie these interactions is critical. Previous studies suggested that the innate and cellular immune responses are major contributors to HBV clearance [4] . However, the role of humoral immunity in controlling HBV remains poorly characterized.
Antibody production by B cells is critical for the clearance of pathogens and for the establishment of long-term humoral immunity [5] . T follicular helper (TFH) cells are the major CD4 + T cell subset that is essential for full B cell responses, including germinal center reactions, isotype class switching, and antibody affinity maturation [6] . No unique markers of TFH cells have been reported, and TFH cells are currently defined using a combination of several markers that are directly related to the functions of these cells [6] . TFH cells express large amounts of B cell lymphoma 6 (Bcl-6) [7] , which is necessary and sufficient for the development of TFH cells in vivo [8] . Chemokine (C-X-C) receptor 5 (CXCR5) is transiently expressed on CD4 + T cells during their interaction with peptide-MHC, but TFH cells can be distinguished from other T cells by their sustained expression of high levels of CXCR5 [9] . CXCR5 promotes the colocalization of T and B cells [10] . TFH cells express surface molecules that play functional roles in T cell and B cell collaboration, such as inducible costimulator (ICOS), programmed cell-death protein 1 (PD-1), and CD40 ligand (CD40L). TFH cells also secrete interleukin 4 (IL-4) and interleukin 21 (IL-21), which are cytokines that promote growth, differentiation, and class switching in B cells [11] .
The unique localization of TFH cells within germinal centers is a fundamental feature of this subset of T cells [12] .However, it is difficult to obtain lymphoid tissue from patients for research purposes. Therefore, a surrogate strategy is required to assess the quality of TFH cell responses in humans. CXCR5 + T cells are known as circulating TFH cells; these cells share functional properties with TFH cells and appear to represent the circulating memory compartment of TFH cells [13] [14] [15] . In addition, several studies demonstrated that CXCR5 + CD4 + T cells derived from both the circulation and germinal centers potently induce antibody production during co-culture with B cells in vitro [14, 16, 17] . The role of blood CXCR5 + CD4 + T cells in patients with autoimmunity has been explored [13, 14] 
Results
Clinical data from subjects in the five groups Table 1 presents the demographic and clinical characteristics of subjects from the chronic HBV infection and HC groups. A total of 38 patients with chronic HBV infection were recruited, including 17 males and 21 females with ages ranging from 7 to 60 years. The subjects were divided into the following groups according to AASLD guidelines [18] : HBeAg-positive chronic hepatitis B (HBeAg + CHB) (n = 14); immune tolerant carrier (IT) (n = 8); inactive carrier (IC) (n = 10); and HBeAg-negative chronic hepatitis B (HBeAg-CHB) (n = 6). In addition, 12males and 13 females with ages ranging from 23 to 64 years were included as controls. The patients with chronic HBV infection were comparable to the healthy controls with respect to sex and age. All patients with chronic HBV infection were positive for HBV DNA, and half of these patients had elevated levels of ALT and/or AST. Notably, the healthy controls were negative for HBV DNA and had normal ALT and AST levels. A significantly higher frequency of CXCR5 + CD4 + T cells was observed in the chronic HBV infection group than in the HC group. Thus, it was important to determine whether the expression of markers that are typically associated with TFH cells were altered. TFH cells are distinguished from other cell types by the expression of ICOS, PD-1, CD40L, IL-21R, CXCR5, and IL-21. The phenotype of TFH cells was assessed in this study (Figure 2A) . Notably, the expression of ICOS was increased in CXCR5 +
CD4
+ T cells in patients with chronic HBV infection compared to healthy controls (p < 0.05) ( Figure 2B ). More importantly, the percentages of ICOS + CXCR5 + CD4 + T cells were significantly higher in the HBeAg + CHB, IT, IC and HBeAg-CHB groups compared to the HC group (p < 0.05) ( Figure 2C ). Likewise, differential expression of PD-1 was observed between the patients with chronic HBV infection and the healthy subjects (p < 0.01) ( Figure 2D ). In Patients with chronic HBV infection exhibited overexpression of BCL-6, CXCR5, IL-6R, IL-4, and IL-21 mRNA in CXCR5 + CD4 + T cells
As previously discussed, the two groups exhibited differential expression of ICOS, PD-1, CD40L, and IL-21R. + CXCR5 + CD4 + T cells in IC patients were positively correlated with AST (r = 0.698, p < 0.05; r = 0.858, p < 0.01; and r = 0.801, p < 0.01, respectively) ( Figure 6A, B, C) .
Discussion
The role of TFH cells in infectious and autoimmune diseases has attracted recent attention. The mechanisms by which TFH cells develop and the mechanisms by which TFH cells or their associated molecules regulate antibody responses in humans remain largely unknown. Several studies demonstrated that the frequency of CXCR5 + CD4 + T cells was not significantly increased in patients with autoimmune diseases, such as SLE [13] , autoimmune thyroid disease [19] , and juvenile dermatomyositis [14] , compared to healthy controls. In contrast, conflicting results have been obtained concerning the existence of a significantly higher frequency of CXCR5 + CD4
+ T cells in patients with chronic HBV infection than in the HC group [20] . Consistent with previous studies, our findings demonstrated that the percentages of CXCR5 + CD4
+ T cells were increased in patients with chronic HBV infection compared to healthy controls. The data obtained in this study suggest that chronic HBV infection drives CXCR5 + CD4
+ T cell differentiation because in addition to the increased frequency of these cells, the phenotype of CXCR5 + CD4 + T cells is altered. The function of TFH cells is closely related to a combination of markers. In this study, the expression of ICOS was increased in CXCR5 + CD4 + T cells in patients with chronic HBV infection compared to healthy controls. ICOS is not expressed by resting T cells and is rapidly upregulated after TCR stimulation. Previous studies demonstrated that ICOS was required for Bcl6 upregulation and for the initiation of the TFH cell differentiation program [21] . Reduced numbers of TFH cells were observed in the absence of ICOS signals [22] . ICOS delivers costimulatory signals by binding to ICOS ligand (ICOS-L) expressed on antigen presenting cells. In both mice and humans, the interruption of the ICOS-ICOS-L interaction leads to impaired GC reactions, Ab class switching, and affinity maturation [22, 23] . Differential expression of PD-1 was also observed between the two groups. PD-1 signaling plays a major role in inhibiting T cell responses. Previous studies demonstrated that PD-1 was elevated during a viral infection to inhibit chronically activated T cells from causing immunopathology or becoming autoreactive [24] . Accumulating evidence indicates that PD-L1-and/or PD-L2-expressing B cells interacted with PD-1 + TFH cells to regulate germinal center B cell survival and the formation and affinity of long-lived plasma cells [25] . We also found that the proportions of CD40L + CD4 +
CXCR5
+ and IL-21R + CD4 + CXCR5 + cells were higher in patients with chronic HBV infection than in healthy controls. The CD40L/CD40 interaction promotes germinal center formation, immunoglobulin isotype switching, and somatic hypermutation of the Ig to enhance affinity for antigens, as well as the subsequent formation of long-lived plasma cells and memory B cells [26] .
BCL-6 was recently identified as a master regulator of TFH differentiation. Constitutive expression of Bcl-6 drives TFH differentiation in vivo [27] . Previous work demonstrated that GC TFH cells expressed a high level of Bcl-6, while blood CXCR5 + CD4 + T cells failed to express elevated levels of the Bcl-6 protein [28] . In contrast to previous studies, blood CXCR5 + CD4
+ T cells in patients with chronic HBV infection exhibited significantly up-regulated levels of Bcl-6 mRNA compared to healthy controls. IL-21 has been reported to play a role in TFH cell formation and in B cell growth, survival, and isotype switching [29] [30] [31] [32] . Our data demonstrated that IL-21 mRNA was highly expressed in circulating TFH cells in patients with chronic HBV infection. This finding suggests that circulating TFH cells can help naïve B cells to produce antibody via IL-21 in patients with chronic HBV infection. The observation that TFH cells produce IL-4 after parasite infection was confirmed by several studies [33, 34] . IL-4 expression by GC TFH cells that lack other Th2 characteristics is important for murine B cell IgG1 class switching. 
Materials and methods

Patients
A total of 38 patients with chronic HBV infection were recruited from the outpatient service of the Second Affiliated Hospital of Chongqing Medical University from July to November 2012, and 25 healthy volunteers were selected as controls. Individual subjects with HBV infection were confirmed to be positive for both HBsAg and detectable HBV virions for more than 6 months. Subjects infected with the hepatitis A, C, D, or E viruses or the human immunodeficiency virus and patients with a history and clinical features of drug-induced liver injury, alcoholic hepatitis, autoimmune diseases and steatohepatitis were excluded. All of the included patients were naïve and had not been previously treated with nucleoside/nucleotide analog antiviral or immunomodulatory drugs. This study conformed to the ethical guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University. All subjects provided written informed consent.
Samples
Peripheral blood samples were obtained from individual subjects with written informed consent. Levels of HBV DNA were detected using a fully automated real-time PCR machine and the luciferase quantitation detection kit, with a detection limit of 300 copies/mL (Roche Amplicor, Basel, Switzerland). Serum markers of HBV, anti-HAV, anti-HCV and anti-HEV were determined via the Roche electrochemical luminescence method using an Architect i2000 system (Abbott Laboratories, Abbott Park, IL, USA). Serum anti-HDV was analyzed by ELISA according to the manufacturer's instructions (Kehua BioEngineering Co, Ltd, Shanghai, China). Serum levels of AST and ALT were detected using the Automatic Biochemistry Analyzer (Beckman LX-20, Beckman, USA).
Flow cytometry analysis
Five milliliters of heparinized peripheral venous blood was obtained from either healthy volunteers or patients with chronic HBV infection. After removing plasma, the red blood cells were lysed using an NH 4 Cl lysis solution. + T cells were isolated from PBMCs using an autoMACS to achieve >95% purity, as previously described. The employed MACS Cell Separation Reagents contained a CD4 + T cell biotin-antibody cocktail, a CXCR5-biotinantibody, and micro-beads. CD4 + T cells were negatively selected using a CD4 + T cell isolation kit (Miltenyi Biotec, Germany), yielding populations of CD4 + cells with 96-99% purity. Next, CXCR5 + T cells were separated from CD4 + T cells on the AutoMACS via repetitive separation steps using a positive selection kit (Miltenyi Biotec).
Real-time PCR
Total RNA was extracted from blood TFH cells using Trizol (Invitrogen) according to the manufacturer's instructions. The concentration and the purity of the RNA were determined by absorbance at 260/280 nm, and cDNA was synthesized using the PrimeScript RT reagent Kit (TaKaRa, Japan). Relative levels of gene expression were measured by real-time PCR using the SYBRGreen master mix reagent in an ABI PRISM 7300 sequence detection system. The following primers were used: GAPDH (NSO_1236141_039, NSO_1236141_040, Invitrogen), BCL-6 (HP 205513, Origene), CXCR5 (HP205521, Origene), IL-6R (HP200535, Origene), IL-4 (HP200556, Origene), and IL-21 (HP214222, Origene). Amplification began with an initial denaturation for 30 seconds at 95°C followed by 40 cycles of denaturation at 95°C for 5 seconds and annealing and extension at 60°C for 31 seconds. The plate was subsequently read. Each sample was tested in triplicate, and the average values were used for subsequent calculations. The expression of each gene was normalized to the housekeeping gene GAPDH, and expressed values relative to control were calculated using the △△ CT method. Amplified products were visualized using a UV transilluminator in combination with 1.2% agarose gel electrophoresis and ethidium bromide staining.
Statistical analysis
All statistical tests were performed using SPSS software, version 17.0 (SPSS Inc., Chicago, IL, USA). Data were presented as the mean ± SD. The t-test was used to compare two independent variables. Correlations between variables were evaluated using the Pearson correlation test. A twotailed P < 0.05 was considered statistically significant.
